WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,043 Cr | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr | ₹3,121 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,043 Cr |
| Mar2024 | ₹2,791 Cr |
| Mar2023 | ₹3,435 Cr |
| Mar2022 | ₹3,207 Cr |
| Mar2021 | ₹3,121 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,043 Cr | -26.80 | |
| Mar2024 | ₹2,791 Cr | -18.75 | |
| Mar2023 | ₹3,435 Cr | 7.11 | |
| Mar2022 | ₹3,207 Cr | 2.76 | |
| Mar2021 | ₹3,121 Cr | - | |
Compare Total Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹31,661.5 Cr | -0.8% | -1% | 14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -0.8% |
-1% |
14.1% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses